The second PROG tumor derived from patient 53 (also with the STAT1316L mutation, Supplementary Fig. 5) expressed similarly low levels of HLA-A (HLA-A log2 expression in Patient 53 PROG1 = 5.2, PROG2 = 4.5). This evidence concerns the gene HLA-A and neoplasm.